CME Group Inc.CME
ASignal's systematic analysis rates CME as Neutral. CME Group Inc. has a market cap of $96.29B, a P/E of 22.67, a 63.4% net margin, and 0.8% year-over-year revenue growth.
Reflects the latest available analysis · analyzed Aug 1, 2026
The case on CME
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong free cash flow of $2.91B
- Low debt-to-equity ratio of 0.15x indicating solid financial health
- High net profit margin of 63.44%
- Operating cash flow of $4.31B supports earnings quality
- MACD above signal line with expanding histogram suggests strengthening momentum
- RSI at 76.04 indicates overbought conditions
- Very low quick ratio of 0.02x suggesting liquidity concerns
- Minimal Reddit retail interest (only 1 mention)
- Revenue growth YoY at only 0.80%, indicating stagnation
- PEG ratio of 4.66x suggests overvaluation relative to growth
Key facts
Peers
Clustered with CME by analysis-profile similarity.
See the full verdict on CME
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes CME
Most investors never get a second opinion, let alone several. ASignal runs CME past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.